arrow
E

Emmanuelle Clappier

Paris Cite University
H指数:43
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ivosidenib monotherapy in IDH1 mutated myelodysplastic neoplasm/syndrome

伊沃斯登ib单药治疗IDH1突变性骨髓异常增生性肿瘤/综合征

Leukemia
IF13.4
2026-08-250
PRE
Splicing-associated network PAK1-CLK1/4-SRRM1 is a vulnerability to overcome chemoresistance in human and mouse acute myeloid leukemia

剪接相关网络PAK1-CLK1/4-SRRM1是人类和小鼠急性髓系白血病克服化疗耐药的易感靶点

2026-07-080
PRE
CEBP and ZEB2 alterations define three distinct subtypes of B-cell acute lymphoblastic leukemia

CEBP和ZEB2改变定义了三种不同的B细胞急性淋巴细胞白血病亚型

2026-06-150
OAAI
Persistent BCR::ABL1-positive preleukemic stem cells drive late clonal evolution in Philadelphia chromosome-positive ALL

BCR::ABL1阳性持久性前白血病干细胞驱动费城染色体阳性ALL的晚期克隆进化

2026-05-220
OAAI
Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement

NUP98重排的成人急性髓系白血病患者的综合突变谱和临床结局

Leukemia
IF13.4
2026-05-120
PRE
Age‐adapted chemotherapy and MRD‐oriented transplant for Ph-negative acute lymphoblastic leukemia - GRAALL-2014 trial

年龄适应化疗和微小残留病导向移植治疗Ph阴性急性淋巴细胞白血病——GRAALL-2014试验

Blood
IF23.1
2025-10-280
PRE
Myeloid neoplasms risks for germline DDX41 pathogenic variants carriers

携带胚系DDX41致病性变异的髓系肿瘤风险

2025-10-030
PRE
Allogeneic hematopoietic stem cell transplantation in germline DDX41 mutated patients with myeloid malignancies

同种异基因造血干细胞移植在种系DDX41突变伴髓系恶性肿瘤患者中的应用

2025-09-110
OAAI
Asciminib for relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia.

阿西米尼布用于费城染色体阳性复发性或难治性急性淋巴细胞白血病的治疗。

2025-07-040
OAAI
IPSS-M risk and specific sex-associated somatic mutations predict response to ESA therapy in LR-MDS: building a new score

IPSS-M风险和特定性别相关的体细胞突变预测LR-MDS对ESA疗法的反应:构建一个新评分

Blood
IF23.1
2025-06-270
PRE
Inflammatory Signatures in VEXAS Syndrome, Myelodysplasia Cutis, and Sweet Syndrome

VEXAS综合征、骨髓增生异常相关皮肤病变和Sweet综合征中的炎症特征

2025-05-010
PRE
Prognostic significance of monocytic-like phenotype in patients with AML treated with venetoclax and azacytidine

单核细胞样表型在应用维奈克拉和氮杂胞苷治疗的AML患者中的预后意义

2025-04-210
OA
Prognostic Significance of Monocytic-like Phenotype in AML Patients Treated with Venetoclax and Azacytidine

单核细胞样表型在用Venetoclax和Azacytidine治疗的AML患者中的预后意义

BLOOD
IF23.1
2024-11-050
PRE
Inflammatory Waldenstrom Macroglobulinemia Is Associated with Clonal Hematopoiesis: A Multicentric Cohort

炎症性华氏巨球蛋白血症与克隆性造血相关:一项多中心队列研究

BLOOD
IF23.1
2024-11-050
PRE
Determinants of Isolated CNS Relapse in Adults with Philadelphia-Negative Acute Lymphoblastic Leukemia. from Graall-2005 to-2014 Trials

孤立性中枢神经系统复发的危险因素:来自Graall-2005至2014试验的研究。

BLOOD
IF23.1
2024-11-050
PRE
Characteristics and Outcome Determinants in Children, Adolescents and Young Adults Who Failed Tisagenlecleucel for B-Cell Acute Lymphoblastic Leukemia

儿童、青少年和年轻成人接受tisagenlecleucel治疗B细胞急性淋巴细胞白血病失败后的特征及结局决定因素

BLOOD
IF23.1
2024-11-050
PRE
Deciphering bone marrow engraftment after allogeneic stem cell transplantation in humans using single-cell analyses

使用单细胞分析破译人类同种异体干细胞移植后的骨髓植入

2024-10-150
OAAI
Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients
2024-07-051
OAAI
Cutaneous clonal mature plasmacytoid dendritic cell dermatosis in patients with myeloid neoplasms

髓系肿瘤患者的皮肤克隆成熟浆细胞样树突状细胞皮肤病

2024-06-141
OAAI